Sign in
Not yet recruitingNo phase

Optimizing Parameters of Transcranial Temporal Interference Stimulation for Spinocerebellar Ataxia Type 3

Key facts

Who runs it
First Affiliated Hospital of Fujian Medical University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
24 people, planned
Started
7 Aug 2026
Expected to end
28 Feb 2027
Type of study
Interventional, 3 groups
Treatments tested
  • Transcranial Temporal Interference Stimulation (tTIS)
Record updated
1 September 2026

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (14)Hide the full registry criteria

Who can take part

  • A physician-diagnosed SCA3 according to diagnostic criteria, with definite clinical symptoms and confirmed genetic testing
  • Age 18-75 years
  • Baseline total score of SARA: 8-30 points (inclusive); SARA gait function subscore: 2-6 points (inclusive)
  • Willing to participate and provide informed consent
  • Have a reliable caregiver available
  • No severe cognitive impairment that would preclude reliable reporting of adverse events or efficacy during treatment

Who cannot take part

  • History of seizures or convulsions, or a seizure within 6 months prior to enrolment
  • Previous neuromodulation treatment (e.g., rTMS or tDCS) within the past year
  • History of severe traumatic brain injury or intracranial neurosurgery
  • Presence of cardiac pacemakers, cochlear implants, intracranial implanted electronic devices, or other MRI-contraindicated ferromagnetic implants
  • Severe cognitive impairment (Mini-Mental State Examination [MMSE] score ≤ 9) or severe visual, auditory, or speech dysfunction preventing cooperation with scale assessments and study procedures
  • Skin breakdown or inflammation at the electrode placement site, or known allergy to conductive gel or electrode patch adhesives
  • Pregnant or lactating women, or women of childbearing age not using reliable contraception
  • Currently participating in other interventional clinical trials, or planning to participate in other trials that might affect the outcome assessment of this study during the study period

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Spinocerebellar ataxia type 3

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this research study is to identify the optimal biological dose for tTIS that targets DN in SCA3 while achieving the best possible balance between therapeutic efficacy and safety.

The 3 groups in the trial

  • 30 Hz Difference Frequency tTISTreatment being tested

    Transcranial Temporal Interference Stimulation (tTIS) uses a difference frequency (Δf) of 30 Hz.

    Treatment: Transcranial Temporal Interference Stimulation (tTIS)

  • 40 Hz Difference Frequency tTISTreatment being tested

    Transcranial Temporal Interference Stimulation (tTIS) uses a difference frequency (Δf) of 40 Hz.

    Treatment: Transcranial Temporal Interference Stimulation (tTIS)

  • 70 Hz Difference Frequency tTISTreatment being tested

    Transcranial Temporal Interference Stimulation (tTIS) uses a difference frequency (Δf) of 70 Hz.

    Treatment: Transcranial Temporal Interference Stimulation (tTIS)

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy and Safety of Transcranial Temporal Interference Stimulation of the Cerebellar Dentate Nucleus Using Individualized Head Modeling in Patients With Spinocerebellar Ataxia Type 3
Criteria questions
Built from NCT07743866, who can take part
Record updated
1 September 2026